Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2012 (2012), Article ID 902676, 5 pages
http://dx.doi.org/10.1100/2012/902676
Clinical Study

A Clinical Study on Glucosamine Sulfate versus Combination of Glucosamine Sulfate and NSAIDs in Mild to Moderate Knee Osteoarthritis

1Department of Pharmacy Practice, Chalapathi Institute of Pharmaceutical Sicences, Guntur-522034, India
2Department of Pharmacy Practice, International Medical University, no. 126, Jalan Jalil Perkasa 19, Bukit Jalil, Kuala Lumpur-57000, Malaysia
3Department of Pharmacokinetics, Lupin Bioresearch Center, Pune-411021, India
4Department of Pharmacy Practice, Mallige College of Pharmacy, Bangalore-560090, India

Received 14 October 2011; Accepted 4 December 2011

Academic Editor: Shawn Patrick Grogan

Copyright © 2012 Tamil Selvan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Lequesne, K. Brandt, N. Bellamy et al., “Guidelines for testing slow acting drugs in osteoarthritis,” Journal of Rheumatology, vol. 41, pp. 65–71, 1994. View at Google Scholar · View at Scopus
  2. T. E. Towheed, M. J. Judd, M. C. Hochberg, and G. Wells, “Acetaminophen for osteoarthritis,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD004257, 2003. View at Google Scholar · View at Scopus
  3. P. Garnero and P. D. Delmas, “Biomarkers in osteoarthritis,” Current Opinion in Rheumatology, vol. 15, no. 5, pp. 641–646, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. R. M. Rozendaal, B. W. Koes, H. Weinans et al., “The effect of Glucosamine sulphate on osteoarthritis: design of a long-term randomised clinical trial,” BMC Musculoskeletal Disorders, vol. 6, article 20, 2005. View at Publisher · View at Google Scholar · View at PubMed
  5. P. Brooks, “Inflammation as an important feature of osteoarthritis,” Bulletin of the World Health Organization, vol. 81, no. 9, pp. 689–690, 2003. View at Google Scholar · View at Scopus
  6. P. Creamer and M. C. Hochberg, “Osteoarthritis,” The Lancet, vol. 350, no. 9076, pp. 503–509, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. D. T. Felson, Y. Zhang, M. T. Hannan et al., “The incidence and natural history of knee osteoarthritis in the elderly: the Framingham osteoarthritis study,” Arthritis and Rheumatism, vol. 38, no. 10, pp. 1500–1505, 1995. View at Publisher · View at Google Scholar · View at Scopus
  8. R. D. Altman, M. C. Hochberg, R. W. Moskowitcz, and T. J. Schnitzer, “Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American college of rheumatology subcommittee on osteoarthritis guidelines,” Arthritis & Rheumatism, vol. 43, pp. 1905–1915, 2000. View at Google Scholar
  9. P. Mainil-Varlet, T. Aigner, M. Brittberg et al., “Histological assessment of cartilage repair: a report by the histology endpoint committee of the international cartilage repair society (ICRS),” Journal of Bone and Joint Surgery A, vol. 85, supplement 2, pp. 45–57, 2003. View at Google Scholar · View at Scopus
  10. B. F. Mandell, “COX-2 inhibitors: balancing the hope, the hype, and the concern,” Cleveland Clinic Journal of Medicine, vol. 68, no. 11, p. 899, 2001. View at Google Scholar · View at Scopus
  11. K. Gaffney, J. Ledingham, and J. D. Perry, “Intra-articular triamcinolone hexacetonide in knee osteoarthritis: factors influencing the clinical response,” Annals of the Rheumatic Diseases, vol. 54, no. 5, pp. 379–381, 1995. View at Google Scholar · View at Scopus
  12. J. P. Raynauld, C Buckland-Wright, and R. Ward, “Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee,” Arthritis & Rheumatism, vol. 48, pp. 370–377, 2003. View at Google Scholar
  13. F. Richy, O. Bruyere, O. Ethgen, M. Cucherat, Y. Henrotin, and J. Y. Reginster, “Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis,” Archives of Internal Medicine, vol. 163, no. 13, pp. 1514–1522, 2003. View at Publisher · View at Google Scholar · View at PubMed
  14. J. Y. Reginster, R. Deroisy, L. C. Rovati et al., “Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial,” The Lancet, vol. 357, no. 9252, pp. 251–256, 2001. View at Publisher · View at Google Scholar · View at PubMed
  15. K. M. Jordan, N. K. Arden, and M. Doherty, “EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the standing committee for international clinical studies including therapeutic trials (ESCISIT),” Annals of the Rheumatic Diseases, vol. 62, pp. 1145–1155, 2003. View at Google Scholar
  16. T. Stürmer, H. Brenner, W. Koenig, and K. P. Gunther, “Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein,” Annals of the Rheumatic Diseases, vol. 63, no. 2, pp. 200–205, 2004. View at Publisher · View at Google Scholar
  17. M. C. Jensen, M. N. Brant-Zawadzki, N. Obuchowski, M. T. Modic, D. Malkasian, and J. S. Ross, “Magnetic resonance imaging of the lumbar spine in people without back pain,” The New England Journal of Medicine, vol. 331, no. 2, pp. 69–73, 1994. View at Publisher · View at Google Scholar · View at PubMed
  18. I. Setnikar, R. Palumbo, S. Canali, and G. Zanolo, “Pharmacokinetics of glucosamine in man,” Arzneimittel-Forschung, vol. 43, no. 10, pp. 1109–1113, 1993. View at Google Scholar
  19. I. Setnikar, C. Giacchetti, and G. Zanolo, “Pharmacokinetics of glucosamine in the dog and in man,” Arzneimittel-Forschung, vol. 36, no. 4, pp. 729–735, 1986. View at Google Scholar
  20. I. Setnikar, C. Giachetti, and G. Zanolo, “Absorption, distribution and excretion of radioactivity after a single intravenous or oral administration of [14C] glucosamine to the rat,” Pharmatherapeutica, vol. 3, no. 8, pp. 538–550, 1984. View at Google Scholar
  21. K. Karze and K. J. Lee, “Effect of hexosamine derivatives on mesenchymal metabolic processes of in vitro cultured fetal bone explants,” The Journal of Rheumatology, vol. 41, no. 2, pp. 212–218, 1982. View at Google Scholar
  22. I. Setnikar, R. Cereda, M. A. Pacini, and L. Revel, “Anti-reactive properties of glucosamine sulfate,” Arzneim Forsch, vol. 41, pp. 157–161, 1991. View at Google Scholar
  23. M. T. Murray, “Glucosamine sulfate: effective osteoarthritis treatment,” American Journal of Natural Medicine, vol. 1, no. 1, pp. 10–14, 1994. View at Google Scholar
  24. E. D. D’Ambrosio, B. Casa, and R. Bompani, “Glucosamine sulphate: a controlled clinical investigation in arthrosis,” Pharmatherapeutica, vol. 2, pp. 504–508, 1981. View at Google Scholar
  25. G. Crolle and E. D'Este, “Glucosamine sulphate for the management of arthrosis: a controlled clinical investigation,” Current Medical Research and Opinion, vol. 7, no. 2, pp. 104–109, 1980. View at Google Scholar · View at Scopus
  26. A. Lopes Vaz, “Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate in the management of osteoarthrosis of the knee in out-patients,” Current Medical Research and Opinion, vol. 8, no. 3, pp. 145–149, 1982. View at Google Scholar · View at Scopus
  27. L. C. Rovati, “Clinical research in osteoarthritis: design and results of short-term and long-term trials with disease-modifying drugs,” International Journal of Tissue Reactions, vol. 14, no. 5, pp. 243–251, 1992. View at Google Scholar · View at Scopus
  28. G. X. Qiu, S. N. Gao, G. Giacovelli, L. Rovati, and I. Setnikar, “Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis,” Arzneimittel-Forschung/Drug Research, vol. 48, no. 5, pp. 469–474, 1998. View at Google Scholar · View at Scopus
  29. M. J. Tapadinhas, I. C. Rivera, and A. A. Bignamini, “Oral glucosamine sulphate in the management of arthrosis: report on a multi-centre open investigation in Portugal,” Pharmatherapeutica, vol. 3, no. 3, pp. 157–168, 1982. View at Google Scholar · View at Scopus
  30. P. Senin, F. Makovec, and L. Rovati, “Stable compounds of glucosamine sulphate,” United States Patent, vol. 4, p. 642, 1987.